Mehdi Sheikh Arabi

Mehdi Sheikh Arabi

Auto-generated profile, based on publicly available information

Mehdi Sheikh Arabi


Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 August 2010 in The Journal of Organic Chemistry
Verified
Journal Article
Closed access
KBKiumars Bahrami
Kiumars Bahrami
MKMohammad M. Khodaei
Mohammad M. Khodaei
MAMehdi Sheikh Arabi
Mehdi Sheikh Arabi

1 December 2016 in Journal of CO2 Utilization
Verified
Journal Article
Closed access
NSNasrin Sadeghi
Nasrin Sadeghi
SSS. Sharifnia
S. Sharifnia
MAM. Sheikh Arabi
M. Sheikh Arabi

8 February 2016 in New Journal of Chemistry
Verified
Journal Article
Closed access
PDF file
KBKiumars Bahrami
Kiumars Bahrami
MAMehdi Sheikh Arabi
Mehdi Sheikh Arabi
The synthesis, characterisation and catalytic activity of FMNP@TD–Cu(ii) for the synthesis of 1,4-disubstituted 1,2,3-triazoles are reported.

1 September 2013 in Tetrahedron Letters
Verified
Journal Article
Closed access
KBKiumars Bahrami
Kiumars Bahrami
MKMohammad M. Khodaei
Mohammad M. Khodaei
HTHoma Targhan
Homa Targhan
MAMehdi Sheikh Arabi
Mehdi Sheikh Arabi

26 February 2021 in Molecular Biology Reports
Verified
Journal Article
Closed access
PDF file
EKEmad Khodadadi
Emad Khodadadi
SMSoleiman Mahjoub
Soleiman Mahjoub
MAMehdi Sheikh Arabi
Mehdi Sheikh Arabi
HNHossein Najafzadehvarzi
Hossein Najafzadehvarzi
VNVahid Nasirian
Vahid Nasirian

2 March 2024 in Journal of Infection and Chemotherapy
Verified
Journal Article
Open access
ENEhsan Najari
Ehsan Najari
SZSamin Zamani
Samin Zamani
MAMehdi Sheikh Arabi
Mehdi Sheikh Arabi
AAAbdollah Ardebili
Abdollah Ardebili
Development of multi-, extensively-, and pandrug-resistant (MDR, XDR, and PDR) strains of Pseudomonas aeruginosa remains a major problem in medical care. The present study evaluated the effect of antimicrobial photodynamic therapy (aPDT) as a monotherapy and in combination with colistin against P. aeruginosa isolates. Two P. aeruginosa isolates recovered from patients with respiratory tract infections were examined in this study. Minimum inhibitory concentration (MIC) of colistin was determined by the colistin broth disk elution (CBDE) and the reference broth microdilution (rBMD) methods. aPDT was performed using the photosensitizer (Ps) riboflavin at several concentrations and a light-emitting diode (LED) emitting blue light for different irradiation times with or without colistin at 1/2 × MIC concentration. Both PA1 and PA2 isolates were identified as colistin-resistant P. aeruginosa with a MIC ≥4 μg/mL by the CBDE and MICs of 512 μg/mL and 256 μg/mL, respectively, by the rBMD. In aPDT, neither riboflavin nor LED light alone had antibacterial effects. The values of colony forming units per milliliter (CFU/mL) in both isolates were significantly reduced by LED + Ps treatments in a time-dependent manner (LED irradiation time) and dose-dependent manner (Ps concentration). In comparison with control, treatment with Ps (50 μM) + LED (120 s) and Ps (100 μM) + LED (120 s) resulted in 0.27 log10 CFU/mL and 0.43 log10 CFU/mL reductions in PA1, and 0.28 log10 CFU/mL and 0.34 log10 CFU/mL reductions in PA2, respectively, (P < 0.01). The best results were obtained after the combination of aPDT followed by colistin, which increased bacterial reduction, resulting in a 0.41-0.7 log10 CFU/mL reduction for PA1 and 0.35-0.83 log10 CFU/mL reduction for PA2 (P = 0.001). This study suggests the potential implications of aPDT in combination with antibiotics, such as colistin for treatment of difficult-to-treat P. aeruginosa infections.